Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002234764 | SCV000949330 | likely benign | Ehlers-Danlos syndrome, classic type, 1 | 2024-10-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000997625 | SCV002526378 | uncertain significance | not provided | 2022-05-26 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function |
ARUP Laboratories, |
RCV005231366 | SCV005877079 | uncertain significance | Ehlers-Danlos syndrome, classic type, 2 | 2023-12-19 | criteria provided, single submitter | clinical testing | The COL5A2 c.2981T>C; p.Ile994Thr variant (rs1354785209), to our knowledge, is not reported in the medical literature but is reported in ClinVar (Variation ID: 653415). This variant is only observed on two alleles in the Genome Aggregation Database (v2.1.1), indicating it is not a common polymorphism. Computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.616). Due to limited information, the clinical significance of this variant is uncertain at this time. |